APA (7th ed.) Citation

Li, J., Shan, K., Huang, W., Su, Q., Qi, Y., Zhang, Z., . . . Du, E. The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Jingxian, Kun Shan, Wei Huang, Qiang Su, Yuanjiong Qi, Zhihong Zhang, Jianqiang Zhu, and E. Du. The Combination Treatment of RC48 and STAT3 Inhibitor Acts as a Promising Therapeutic Strategy for Basal Bladder Cancer. Frontiers Media S.A.

MLA (9th ed.) Citation

Li, Jingxian, et al. The Combination Treatment of RC48 and STAT3 Inhibitor Acts as a Promising Therapeutic Strategy for Basal Bladder Cancer. Frontiers Media S.A.